I am a
Home I AM A Search Login

Papers of the Week

Papers: 21 May 2022 - 27 May 2022

Human Studies

2022 May 25

JAMA Dermatol

Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.


Asdourian MS, Shah N, Jacoby TV, Reynolds KL, Chen ST
JAMA Dermatol. 2022 May 25.
PMID: 35612829.


There is limited information on immune checkpoint inhibitor-induced bullous pemphigoid (ICI-BP) in patients with cancer, with most existing studies being case reports or small case series from a single institution. Prior review attempts have not approached the literature in a systematic manner and have focused only on ICI-BP secondary to anti-programmed cell death 1 (PD-1) or programmed cell death ligand 1 (PD-L1) therapy. The current knowledge base of all aspects of ICI-BP is limited.